Page last updated: 2024-11-03

procarbazine and Blindness

procarbazine has been researched along with Blindness in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sangave, A1
Faia, LJ1
Yeh, S1
Chan, CC1
Nussenblatt, RB1
Sen, HN1

Other Studies

1 other study available for procarbazine and Blindness

ArticleYear
A case of rapid progression and vision loss in a patient with primary intraocular lymphoma.
    Ocular immunology and inflammation, 2010, Volume: 18, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Disease Progression; Eye Neoplasms;

2010